These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4218239)

  • 1. Host-virus relationship with special reference to Newcastle disease and serum hepatitis.
    Waterson AP
    J Clin Pathol Suppl (R Coll Pathol); 1972; 6():1-7. PubMed ID: 4218239
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of virulence of Newcastle disease.
    Hanson RP
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):482-9. PubMed ID: 286363
    [No Abstract]   [Full Text] [Related]  

  • 3. The viscerotropic pathotype of Newcastle disease virus.
    Hanson RP; Spalatin J; Jacobson GS
    Avian Dis; 1973; 17(2):354-61. PubMed ID: 4712806
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical disease produced in chickens by Newcastle disease virus isolated from exotic birds.
    Brugh M; Beard CW
    Avian Dis; 1984; 28(2):482-8. PubMed ID: 6743179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Australia-antigen (HB Ag) and hepatitis in childhood (author's transl)].
    Hellwege HH
    Monatsschr Kinderheilkd (1902); 1974 Dec; 122(12):893-9. PubMed ID: 4141054
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of chickens afforded by commercial lentogenic vaccines against challenge exposure to velogenic Newcastle disease virus.
    Butterfield WK; Dardiri AH; Yedloutschnig RJ
    Avian Dis; 1973; 17(2):279-82. PubMed ID: 4712800
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of communicability of a Newcastle disease virus to its resistance to a respiratory inhibitor.
    Gustafson J; Hanson RP
    Avian Dis; 1982; 26(1):60-3. PubMed ID: 7092746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reemergence of Newcastle disease.
    Hanson RP
    Adv Vet Sci Comp Med; 1974; 18(0):213-29. PubMed ID: 4608990
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and biological properties of some Moroccan strains of Newcastle disease virus.
    Bell JG; Berrada J; Wyffels R; el Houadfi M
    Avian Dis; 1984; 28(2):319-22. PubMed ID: 6743170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of KB cells in the diagnosis of Newcastle's disease and titration of the virus].
    Ramisse J; Serres H; Rakotondramary E
    Rev Elev Med Vet Pays Trop; 1969; 22(4):443-52. PubMed ID: 4926337
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of neutralizing (SN) and hemagglutination inhibiting (HI) antibodies on the course of Newcastle disease infection in chickens].
    Borzemska WB
    Pol Arch Weter; 1972; 15(3):495-512. PubMed ID: 4662589
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccination against Newcastle disease significance of strain diversity.
    Jørgensen PH
    Acta Vet Scand Suppl; 1996; 90():53-6. PubMed ID: 8996886
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of the B-1 and VG/GA vaccine strains against velogenic viscerotropic Newcastle disease virus in chickens.
    Beard CW; Villegas P; Glisson JR
    Avian Dis; 1993; 37(1):222-5. PubMed ID: 8452500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Precipitinogen activity of Newcastle disease virus and humoral immunity in birds].
    Surtmadzhiev K; Gerganov G
    Vet Med Nauki; 1982; 19(2):11-7. PubMed ID: 7112927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative tests of the harmlessness of the activity between the B 1 and LaSota strains of the Newcastle disease virus].
    Lombardi D
    Acta Med Vet (Napoli); 1966; 12(3):275-85. PubMed ID: 5965597
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of solid phase antigen for indirect ELISA for the detection of specific antibody responses to infection with Newcastle disease virus.
    Sahle M; Burgess GW
    Onderstepoort J Vet Res; 2002 Sep; 69(3):237-42. PubMed ID: 12356171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plaque activity of vaccinal and epizootic Newcastle virus].
    Obreshkov K; Dilovski M
    Vet Med Nauki; 1977; 14(10):9-13. PubMed ID: 610047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis.
    Hsu HY; Chang MH; Ni YH; Lin HH; Wang SM; Chen DS
    Hepatology; 1997 Sep; 26(3):786-91. PubMed ID: 9303514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo persistence of plaque mutants of viscerotropic Newcastle disease virus].
    Gerganov G; Surtmadzhiev K
    Vet Med Nauki; 1981; 18(7):26-33. PubMed ID: 7046219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.